The metabolomics services market was valued at USD 111.5 million in the year 2021 and is anticipated to grow USD 254.30 million by 2028 at CAGR of 12.5% over the forecast years 2022-2028 due to growing integration of metabolomics data into clinical workflows such as growth of newborn genetic screening programs, advancements in noninvasive cancer screening and increasing interest towards targeted and personalized healthcare. Moreover, Increase in government role and funding in metabolomics and technological advances to facilitate metabolomic R&D are the major factors that are driving the growth of the global metabolomics services market over the forecast timeframe. This report studies global metabolomics services market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Some of the major and important factors that will likely accelerate the growth of the metabolomics services market in the future include an increase in the number of patients suffering from neurological disorders, cancer, and cardiac diseases, increased growth of the healthcare industry globally, increased demand for personalised medicine, and an increase in the need for accurate disease diagnosis.
View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-metabolomics-services-market/
Integration of metabolomics data into clinical workflows is a key factor drive the global metabolomics services market. The data obtained from the metabolite screening of a person helps in understanding the profile of that person which ultimately play a major role in the personalized treatment of the person. The metabolomic data that was obtained will also help to screen various life threatening diseases like cancer, cardiovascular diseases and various genetic disorders, this is very beneficial for those who are at risk of getting the disease as they can take precautionary measures for the disease. Moreover, the increasing number of research projects in metabolomics, increasing number of biotechnological industries that are showing more interest towards metabolomics services are the factors believed to propel the global market over the forecast years.
North America accounted for larger revenue share in global metabolomics services market with significant CAGR. Increase in demand for personalized and targeted health care, increasing research funding and government initiatives in metabolomics and availability of sophisticated healthcare infrastructure are anticipated to propel the market. Asia pacific metabolomics services market projected to grow at significant rate owing to enhanced demand for biomarkers for the diagnosis of various life threatening diseases and enhanced awareness about various metabolomics technologies in the emerging countries such as China and India for detection, treatment, and prognosis of various genetic disorders such as diabetes, cancer, and other life threatening diseases.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16500
There are several industry players working in the Metabolomics Services Market, which include Waters Corporation (US) Agilent Technologies (US) Shimadzu Corporation (Japan) Thermo Fisher Scientific (US) Danaher Corporation (US) Bruker Corporation (US)
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: [email protected]
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
